Cardlytics Posts $32.9M in Q3 Revenue
CDLX sits 39% above its 52-week low of $1.57.
Summary
Cardlytics reported third-quarter revenue of $32.9M, the first hard top-line number out of the company since its Q1 2026 print showed a 39% year-over-year revenue decline. The headline carries no profit, EBITDA, or guidance figures, so the read on whether the revenue slide is stabilizing is incomplete. For a micro-cap trading near $2.19, the revenue level is the number that matters most to the thesis. Watch for the full release and any Q4 guidance to see if the decline is narrowing.
At the time of this announcement, CDLX was trading at $2.19 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.9M. The 52-week trading range was $1.57 to $18.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.